China Sky One Medical (NASDAQOTH:CSKI)

CAPS Rating: 2 out of 5

The company develops, manufactures, markets, and sells over-the-counter, branded nutritional supplements, and over-the-counter plant- and herb-based pharmaceuticals primarily in China.


Player Avatar swingtrader858 (< 20) Submitted: 8/10/2011 3:55:50 PM : Outperform Start Price: $2.55 CSKI Score: -70.13

More cash on balance sheet than the market cap of the stock. Plus, continued positive cash flow and profits with an improved outlook for future products. Company is sticking with R&D spending for future growth.

Member Avatar sisula (22.35) Submitted: 9/3/2011 6:12:35 PM
Recs: 0

There is no cash at all! If there was any, management would buy this company with instant profit!

Featured Broker Partners